ArticlePLoS neglected tropical diseases2025
Leprosy stigma in the healthcare setting: Lived experiences of persons affected by leprosy in Niger.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Understanding influences on health-seeking behaviours among persons cured of leprosy in the Godokpe community, Volta Region of Ghana: A qualitative descriptive study.PLoS neglected tropical diseases · 2026Article
- Leprosy-Related Stigma and Social Representations Among Persons Affected by Leprosy and Primary Healthcare Professionals: A Structural Analysis in the Brazilian Amazon.Journal of community health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Leprosy-related stigma is deeply rooted in history and permeates every aspect of society, and stigmatization by healthcare professionals is no exception. This paper explores the experiences of persons affected by leprosy with stigma in the healthcare setting throughout their treatment-seeking journey. We conducted one-on-one interviews with 112 individuals who experienced a leprosy diagnosis and underwent treatment. Data was collected in July and August 2022, in nine villages and one urban neighborhood in the region of Maradi, Niger. Over two-thirds of participants experienced some form of visible impairment due to leprosy. Throughout their treatment-seeking journey, healthcare providers were reported to have stigmatized patients by using hurtful language, isolating patients, physically distancing from patients, or refusing to treat. The extent of the stigmatization depended on, first, whether leprosy was recognized or not. Unfortunately, many healthcare providers did not detect the early signs of leprosy, therefore, patients were then not able to obtain treatment prior to physical impairment. Second, the level of stigmatization varied based on the degree and type of visible physical impairments (e.g., missing fingers or toes, limbs, blindness). These negative experiences with healthcare workers made treatment-seeking and adherence to treatment regimen less likely for patients. Our findings confirm the presence of leprosy stigma in the healthcare context in Niger. Increasing leprosy knowledge and addressing stigma among healthcare professionals is key to early diagnosis and treatment of leprosy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.